These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28386997)

  • 1. The transformation in biomarker detection and management of drug-induced liver injury.
    Church RJ; Watkins PB
    Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
    Church RJ; Watkins PB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
    Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
    Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.
    Antoine DJ; Dear JW; Lewis PS; Platt V; Coyle J; Masson M; Thanacoody RH; Gray AJ; Webb DJ; Moggs JG; Bateman DN; Goldring CE; Park BK
    Hepatology; 2013 Aug; 58(2):777-87. PubMed ID: 23390034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
    Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.
    Antoine DJ; Jenkins RE; Dear JW; Williams DP; McGill MR; Sharpe MR; Craig DG; Simpson KJ; Jaeschke H; Park BK
    J Hepatol; 2012 May; 56(5):1070-1079. PubMed ID: 22266604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats.
    Maliver P; Festag M; Bennecke M; Christen F; Bánfai B; Lenz B; Winter M
    Toxicol Pathol; 2017 Jun; 45(4):506-525. PubMed ID: 28485676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of cytokeratin-18 as a biomarker for drug-induced liver injury.
    Korver S; Bowen J; Pearson K; Gonzalez RJ; French N; Park K; Jenkins R; Goldring C
    Arch Toxicol; 2021 Nov; 95(11):3435-3448. PubMed ID: 34322741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.
    Thulin P; Nordahl G; Gry M; Yimer G; Aklillu E; Makonnen E; Aderaye G; Lindquist L; Mattsson CM; Ekblom B; Antoine DJ; Park BK; Linder S; Harrill AH; Watkins PB; Glinghammar B; Schuppe-Koistinen I
    Liver Int; 2014 Mar; 34(3):367-78. PubMed ID: 24118944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury.
    Craig DG; Lee P; Pryde EA; Masterton GS; Hayes PC; Simpson KJ
    Liver Int; 2011 Sep; 31(8):1127-36. PubMed ID: 21745283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
    Tonomura Y; Kato Y; Hanafusa H; Morikawa Y; Matsuyama K; Uehara T; Ueno M; Torii M
    J Appl Toxicol; 2015 Feb; 35(2):165-72. PubMed ID: 25186495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Performance Evaluation of Liver and Skeletal Muscle-Specific miRNAs in Rat Plasma to Detect Drug-Induced Injury.
    Bailey WJ; Barnum JE; Erdos Z; LaFranco-Scheuch L; Lane P; Vlasakova K; Sistare FD; Glaab WE
    Toxicol Sci; 2019 Mar; 168(1):110-125. PubMed ID: 30496518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.
    Harrill AH; Roach J; Fier I; Eaddy JS; Kurtz CL; Antoine DJ; Spencer DM; Kishimoto TK; Pisetsky DS; Park BK; Watkins PB
    Clin Pharmacol Ther; 2012 Aug; 92(2):214-20. PubMed ID: 22739141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).
    Scullion KM; MacIntyre IM; Sloan-Dennison S; Clark B; Fineran P; Mair J; Creasey D; Rathmell C; Faulds K; Graham D; Webb DJ; Dear JW
    Toxicol Sci; 2024 May; 199(2):203-209. PubMed ID: 38521541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.
    Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.
    Cueto-Sánchez A; Niu H; Álvarez-Álvarez I; López-Longarela B; Del Campo-Herrera E; Ortega-Alonso A; García-Cortés M; Pinazo-Bandera J; Sanabria-Cabrera J; Díaz-Mochón JJ; Lucena MI; Andrade RJ; Stephens C; Robles-Díaz M
    Br J Clin Pharmacol; 2023 Aug; 89(8):2497-2507. PubMed ID: 36965054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies.
    Sharapova T; Devanarayan V; LeRoy B; Liguori MJ; Blomme E; Buck W; Maher J
    Vet Pathol; 2016 Jan; 53(1):211-21. PubMed ID: 26123229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.